» Articles » PMID: 29209320

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands During Inflammation

Overview
Journal Front Immunol
Date 2017 Dec 7
PMID 29209320
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Mucosal epithelia encounter both physicochemical and biological stress during their life and have evolved several mechanisms to deal with them, including regulation of immune cell functions. Stressed and damaged cells need to be cleared to control local inflammation and trigger tissue healing. Engagement of the activating NKG2D receptor is one of the most direct mechanisms involved in the recognition of stressed cells by the immune system. Indeed, injured cells promptly express NKG2D ligands that in turn mediate the activation of lymphocytes of both innate and adaptive arms of the immune system. This review focuses on different conditions that are able to modulate NKG2D ligand expression on the epithelia. Special attention is given to the mechanisms of immunosurveillance mediated by natural killer cells, which are finely tuned by NKG2D. Different types of stress, including viral and bacterial infections, chronic inflammation, and cigarette smoke exposure, are discussed as paradigmatic conditions for NKG2D ligand modulation, and the implications for tissue homeostasis are discussed.

Citing Articles

Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in infection.

Anthofer M, Windisch M, Haller R, Ehmann S, Wrighton S, Miller M Front Immunol. 2024; 15:1282680.

PMID: 38318189 PMC: 10839011. DOI: 10.3389/fimmu.2024.1282680.


Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway.

Zhang J, Luo Q, Li X, Guo J, Zhu Q, Lu X Biomark Res. 2023; 11(1):86.

PMID: 37784183 PMC: 10546648. DOI: 10.1186/s40364-023-00530-4.


CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies.

Trinh T, Adams W, Calescibetta A, Tu N, Dalton R, So T iScience. 2023; 26(4):106443.

PMID: 37070068 PMC: 10105289. DOI: 10.1016/j.isci.2023.106443.


NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes.

Calabrese D, Tsao T, Magnen M, Valet C, Gao Y, Mallavia B JCI Insight. 2022; 7(24).

PMID: 36346670 PMC: 9869973. DOI: 10.1172/jci.insight.164603.


Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.

Jones A, Rocco A, Lamb L, Friedman G, Hjelmeland A Cancers (Basel). 2022; 14(9).

PMID: 35565467 PMC: 9105350. DOI: 10.3390/cancers14092339.


References
1.
Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A . Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood. 2007; 110(2):606-15. DOI: 10.1182/blood-2006-10-052720. View

2.
Ogasawara K, Hamerman J, Ehrlich L, Bour-Jordan H, Santamaria P, Bluestone J . NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity. 2004; 20(6):757-67. DOI: 10.1016/j.immuni.2004.05.008. View

3.
Bhagat G, Naiyer A, Shah J, Harper J, Jabri B, Wang T . Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest. 2007; 118(1):281-93. PMC: 2117760. DOI: 10.1172/JCI30989. View

4.
Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M . Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology. 2000; 119(4):996-1006. DOI: 10.1053/gast.2000.18149. View

5.
Ferguson L, Shelling A, Browning B, Huebner C, Petermann I . Genes, diet and inflammatory bowel disease. Mutat Res. 2007; 622(1-2):70-83. DOI: 10.1016/j.mrfmmm.2007.05.011. View